Evidence-Based Recommendations—GRADE
See complete list of GRADE materials linked from MMWR
About GRADE
CDC vaccine recommendations are developed using an explicit evidence-based method based on the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
Key factors considered in development of recommendations include balance of benefits and harms, type or quality of evidence, values and preferences of the people affected, and health economic analyses.
- Category A recommendations are made for all persons in an age- or risk-factor-based group.
- Category B recommendations are made for individual clinical decision making.
- Evidence tables are used to summarize the benefits and harms and the strengths and limitations of the body of evidence.
Resources for Learning More About GRADE
- GRADE Working Group web site
Full description and answers to frequently asked questions about GRADE- GRADE online learning modules
These online learning modules are designed to help guideline developers and authors of systematic reviews learn how to use the GRADE approach to grade the evidence in systematic reviews, to create Summary of Findings Tables and GRADE Evidence Profiles, and move from evidence to making recommendation
- GRADE online learning modules
- Video: The GRADE Approach - An Introductory Workshop on Making Recommendations
Sept 9, 2011, CDC, Atlanta, GA.- Video part 1: Overview of the GRADE Approach and the Process [88:07 minutes]
- Video part 2: Assessing the Quality of Evidence [100:62 minutes]
- Slide presentations:
- New Framework for Developing Evidence-Based Recommendations by the ACIP [461 KB, 66 pages] – Dr Faruque Ahmed, CDC, December 15, 2011.
- Guideline Development Using GRADE [5 MB, 235 pages] – Dr Holger Schünemann, McMaster University, Canada; from Introductory GRADE Workshop, Sept 9, 2011.
- Publications:
- CDC. New Framework (GRADE) for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices. MMWR. 2012;61(18):327-327.
- Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ. Methods for developing evidence-based recommendations by the ACIP of the CDC – Vaccine 2011;29(49):9171-9176.
- Matysiak-Klose D, Ahmed F, Duclos P, Falck-Ytter Y, Forland F, Houweling H, et al. Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010 – Vaccine 2012;30(14):2399-404.
- Handbook:
- Ahmed et al. U.S. ACIP Handbook for Developing Evidence-based Recommendations [611 KB, 46 pages]. Version 1.1. Atlanta, GA: Centers for Disease Control and Prevention (CDC); 2012.
Practical handbook for use by ACIP Work Groups in development of evidence-based recommendations for presentation to the Advisory Committee on Immunization Practices.
- Ahmed et al. U.S. ACIP Handbook for Developing Evidence-based Recommendations [611 KB, 46 pages]. Version 1.1. Atlanta, GA: Centers for Disease Control and Prevention (CDC); 2012.
- World Health Organization Vaccine Position Papers:
- Vaccine Position Papers
Including Grading of Scientific Evidence documents
- Vaccine Position Papers
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.
Contact ACIP
-
Advisory Committee on Immunization Practices (ACIP)
1600 Clifton Road, N.E., Mailstop A27
Atlanta, GA 30333 - 1-404-639-8836
- acip@cdc.gov
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
Contact CDC-INFO



